---
document_datetime: 2025-10-30 16:40:45
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/teysuno-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: teysuno-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.9555153
conversion_datetime: 2025-12-17 08:25:00.351784
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Teysuno

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber    | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | This was an application for a group of | 30/10/2025                          |                                          | Annex II and                    |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII,Labelling,PL(PackageLeaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonths of the opinionforvariationsfallingunderthescope ofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000308441   | PL   |
|---------------------|------|

<div style=\"page-break-after: always\"></div>

|                                          | B.II.b.2.cReplacement or addition of a manufacturerresponsibleforimportation and/or batch release - B.11.b.2.c.2 Including batch control/testing-Accepted                                                                                                                                                                                                                                                                        |            |             |                                                                                                                                                    |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IA_IN / EMA/VR/0000273132 | C.IHUMANANDVETERINARYMEDICINAL PRODUCTS - C.I.z Change(s) in the SmPC, labelling or package leaflet of human medicinal products in order to adapt to a recommendation of a competent authority , e.g. a Core SmPC, following the assessment of anUrgentSafetyRestrictionetc. Implementationofwordingagreedbythe competent authority that require additional minor assessment,e.g.translations are not yet agreed upon.- Accepted | 21/05/2025 | SmPC and PL | To update sections 4.4 and 4.8 of the SmPC and sections 2 and 4 of the PL with agreed text on hyperammonaemia following a safety signal procedure. |